Concepedia

Els Genbrugge

EG

5

Publications

312

Citations

5

H-Index

2018

Active since

Affiliations

University of Zurich(Current)

European Organisation for Research and Treatment of Cancer

Heidelberg University

University of Alabama at Birmingham

University Hospital of Zurich

Els Genbrugge is an author at University of Zurich specializing in neurology, hematology, and pharmacotherapy.

ORCID

Top concepts

Publications per year

2018–2021

5

Publications

5

<i>MGMT</i> Promoter Methylation Cutoff with Safety Margin for Selecting Glioblastoma Patients into Trials Omitting Temozolomide: A Pooled Analysis of Four Clinical Trials

Monika E. Hegi, Els Genbrugge, Thierry Gorlia et al. · Clinical Cancer Research · 2018 · 139 citations · Full text

Temporal muscle thickness is an independent prognostic marker in patients with progressive glioblastoma: translational imaging analysis of the EORTC 26101 trial

Julia Furtner, Els Genbrugge, Thierry Gorlia et al. · Neuro-Oncology · 2019 · 90 citations · Full text

Use of metformin and outcome of patients with newly diagnosed glioblastoma: Pooled analysis

Corinna Seliger, Els Genbrugge, Thierry Gorlia et al. · International Journal of Cancer · 2019 · 59 citations · Full text

Associations of anticoagulant use with outcome in newly diagnosed glioblastoma

Émilie Le Rhun, Els Genbrugge, Roger Stupp et al. · European Journal of Cancer · 2018 · 14 citations

, , +13

Insights into the association of ACEIs/ARBs use and COVID-19 prognosis: a multistate modelling study of nationwide hospital surveillance data from Belgium

José L. Peñalvo, Els Genbrugge, Elly Mertens et al. · BMJ Open · 2021 · 10 citations · Full text

Rows per page

1–5 of 5